Browsing Tag
Junshi Biosciences
2 posts
Could subcutaneous PD-1 therapy reshape oncology treatment logistics in China?
Could subcutaneous PD-1 therapy reshape cancer treatment in China? Explore Junshi Biosciences’ toripalimab filing and its impact on oncology logistics.
Mabwell’s adalimumab biosimilar wins BPOM nod: Is Southeast Asia becoming the next battleground for biosimilars?
Mabwell’s adalimumab biosimilar wins approval in Indonesia. Find out what this means for Southeast Asia’s biologics market and Mabwell’s global ambitions.